FDA issues urgent recall on Coca-Cola after disturbing discovery found in nearly 900 cases — here's what it found
Hundreds of cases of Coca-Cola Original Taste aren't living up to the billing because customers have reported that they found plastic inside of some cans, according to Newsweek.
The recall, initiated March 6, impacts 864 separate 12-packs in Illinois and Wisconsin with a date code of "SEP2925MDA." The Food and Drug Administration listed it as a Class II recall. That means that exposure to the beverage could cause "temporary or medically reversible adverse health consequences," per Newsweek.
"We are taking this voluntary action because nothing is more important to us than providing high-quality products to the people who drink our beverages," a Coca-Cola spokesperson told the publication.
Consuming plastic is one way the troublesome and prolific substances are entering the body in smaller forms called microplastics, as noted by Harvard Medicine. Experts are studying how the particles are harming humans, including possible inflammation and kidney damage.
The news is part of a mixed bag of headlines for Coca-Cola. In India, the well-known brand pushed recycling's importance by giving out thousands of jackets made with reused bottles. Other reports highlighted a cleaner solar energy project at an Indian production site.
On the other hand, the company has been criticized for using loads of water in drought-hit Mexico during a time when residents were struggling to find clean H2O, HipLatina reported. Coca-Cola is also no stranger to plastic waste, often referred to as the company responsible for the most plastic pollution in the world. And this isn't its first safety recall, either.
For the brand's part, 1.9 billion servings are produced daily. At that scale, it's tough to avoid recalls entirely. And it's something that happens for a wide range of products (even clams), for a variety of reasons.
Scientific American listed some of the more troubling ones as of 2017. In 2011, lead was found in bubblegum. In 2017, a dead bat turned up in a packaged salad. Plastic contamination was on the list a couple of times for various products.
That's likely why about 81% of respondents surveyed late last year by CivicScience were at least "somewhat" concerned about recalls after a recent spree of them.
Supporting brands that use plastic-free packaging is a great way to encourage planet-friendly manufacturing. And avoiding single-use products is another way to help. A reusable water bottle, for example, can save you hundreds of bucks annually while providing a better experience.
Do you worry about the quality of the air inside your home?
Yes — often
Yes — but only sometimes
Only when it's bad outside
No — I never do
Click your choice to see results and speak your mind.
What's more, experts are learning that eating more fruits and veggies can help to negate some of the harm microplastics can cause in our bodies.
The government also has a couple of sites that provide updates on products to avoid.
For reference, the recall number on the Coca-Cola concern is "F-0664-2025." The production time stamps are between 11:00 and 12:53. Impacted packs have a single-can UPC of "0 49000-00634 6" and a 12-pack UPC of "0 49000-02890 4," according to Newsweek.
Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
9 hours ago
- Newsweek
Gen Zer Reaches Final Stage of Chemo—Has No Idea Devastating News Is Coming
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. When Alexis Klimpl discovered a grape-sized lump in her breast, her gut immediately told her it was cancer. But due to her young age, she tried to convince herself it couldn't be. However, a series of tests and scans confirmed the worst: she had stage 2 triple-positive breast cancer at just 24 years old. Now, one year later, the publicist from San Diego, California, is in remission. But she's also navigating early menopause brought on by her treatment. "I can't have kids for 10 more years because of the medication I'm on," she told Newsweek. Klimpl takes Lupron, a drug used to reduce the risk of hormone-receptor-positive breast cancer returning in premenopausal women following surgery and other treatments. She also takes Letrozole, a hormone blocker. "I never thought I'd be in menopause at 25," she said. "I have 10 to 15 hot flashes a day, night sweats, ongoing hair loss, vaginal dryness and mood swings." Most women begin the menopausal transition between the ages of 45 and 55, with symptoms often lasting for several years. Breast cancer, too, is typically associated with older women—the American Cancer Society reports that the median age at diagnosis is 62. Although uncommon, a small percentage of cases do occur in women under 45. L-R: Klimpl with her partner and Klimpl sitting in the hospital during cancer treatment. L-R: Klimpl with her partner and Klimpl sitting in the hospital during cancer treatment. Alexis Klimpl Dr. Mary Jane Minkin, the co-director of the sexuality, intimacy and menopause for cancer survivors program at Smilow Cancer Hospital in New Haven, Connecticut, explained to Newsweek why patients like Klimpl go through a medicated menopause. "The problem here is that for a woman who has (presumed) estrogen receptor positive breast cancer, all oncologists would want to avoid giving her estrogen, and indeed would probably give her medications to minimize her own body's production of any estrogen from any non-ovarian source," Minkin said. With no family history of breast cancer, Klimpl and her mother were devastated by the diagnosis. "I thought I was too young to have cancer," she told Newsweek, explaining that she initially hoped it was just a cyst, but she could feel it growing. "When I was diagnosed, the doctors didn't know how it happened. They said it's rare at my age. My mom broke down. Seeing her face—I'll never forget that image," Klimpl said. A friend set up a GoFundMe page for Klimpl that raised $23,000. Half of the funds went toward egg freezing, during which 36 eggs were retrieved. The rest helped cover the costs of six surgeries, each priced at $3,000. L-R: Klimpl flashing a peace sign and with her mother during a hospitalization. L-R: Klimpl flashing a peace sign and with her mother during a hospitalization. Alexis Klimpl/Alexis Klimpl Klimpl underwent six rounds of chemotherapy over the course of nearly five months and was officially declared cancer-free in January of this year. Despite genetic tests showing no inherited cancer risk, she chose to have a double mastectomy. "In my eyes, my breasts betrayed me. They didn't have my back, so I wanted them gone," she said. Klimpl has since undergone breast reconstruction, which she lightheartedly refers to on Instagram (@lexiklimpl) as "the only positive" of her cancer experience. Reflecting on the past year, she told Newsweek: "As a young person, you feel invincible—but being diagnosed at such a young age really put my life into perspective." "It strengthened my relationships with friends and family because they showed up for me in ways I'll never forget. I've realized that we often don't know how to be there for others when we're just trying to keep ourselves together," she said. "I'm finally at a stage where it feels like everything is behind me. I'm returning to my life—but it's strange. I thought that hearing the words 'cancer-free' would bring instant relief, that it would be the moment the stress disappeared. But it wasn't. Recovery is more complex than I expected."
The Hill
15 hours ago
- The Hill
Thanks to imported drugs, America has lost control of its medicine cabinet
America is facing a growing crisis in its medical system — not from a lack of talent or innovation, but from a breakdown in the control, safety and supply of essential medicines. Our growing reliance on imports is now driving serious drug shortages, destabilizing supply chains and increasingly making medications unsafe. At the root of it is a hard truth: We no longer have control of the medicines we depend on every day. In 2002, America manufactured 83.7 percent of the pharmaceuticals it consumed. By 2024, that number had dropped to just 37.1 percent. Meanwhile, the U.S. pharmaceutical trade deficit has soared, reaching a record $118.3 billion in 2024. We didn't just outsource manufacturing — we outsourced the sovereignty and safety of our health care system. This means that nearly two-thirds of America's pharmaceutical supplies are now imported. Most critical medications, such as generic drugs, now come from China and India. China controls 80 to 90 percent of the global supply of active pharmaceutical ingredients — the chemical building blocks of modern medicine. Even drugs labeled 'Made in the USA' often chemically originate in China. And India, which produces about half of America's finished generic drugs, relies on China for up to 80 percent of its active pharmaceutical not a supply chain — it's a ticking time something goes wrong, American patients suffer. In 2023, the Food and Drug Administration shut down a single Indian plant responsible for 50 percent of the U.S. supply of cisplatin, a critical chemotherapy drug, after uncovering a 'cascade of failure' in safety practices and shredded documents soaked in acid. With no domestic backup, patients nationwide had their treatments delayed. That wasn't a fluke. 40 percent of U.S. generic drugs have only one FDA-approved manufacturer. Because of that single chokepoint, when one factory fails, the whole system can crack. We are now seeing widespread drug shortages across the medical system. Hospital pharmacists report an average of 301 critical drug shortages at any given time. And 85 percent say these shortages are moderately or critically affecting care. Doctors often lack crucial medicines such as antibiotics, sedatives and cancer drugs. These aren't obscure drugs. They're foundational medicines. But America no longer makes them. Even when imported drugs do arrive, they're not always safe. A 2025 study found that Indian generics are 54 percent more likely to cause serious side effects than their U.S.-made counterparts. Indian factory violations have also been tied to at least eight U.S. patient deaths. China's record is equally disturbing. In 2008, dozens of Americans died after receiving contaminated heparin from Chinese suppliers. This isn't what the American people want. In a national survey, 85 percent of hospital pharmacists said they would pay more for safer generics. But under today's rules, price overshadows quality. Hospitals have little oversight of drug quality — and foreign producers face few consequences for cutting corners. Even the federal government is flying blind. A 2023 Department of Defense review found that 22 percent of essential military-use drugs had unknown ingredient sourcing. That's a national security April, the Trump administration took a necessary step by launching an investigation into generic pharmaceutical imports that correctly frames the issue as a national security threat. But that recognition alone isn't enough. To address this crisis, Washington should impose targeted tariffs on generic drugs from adversarial nations. It must also rebuild domestic pharmaceutical production through tax credits and long-term contracts. America urgently needs full transparency in drug labeling to disclose where drugs and their ingredients are made. The FDA must step up — with stronger enforcement abroad and a ban on imports from repeat safety violators. And to secure critical ingredients during market disruptions, Washington must pursue a long-term vision that includes a 'strategic pharmaceutical reserve.' This isn't just protectionism. It's a restoration of America's medical security. No nation can call itself sovereign if it can't produce its own medicines, and no patient is safe if their health care depends on quality control in a factory 8,000 miles decades, we were told that offshoring production would make things cheaper, smoother and more efficient. But America can no longer depend on unstable foreign suppliers. It's time to restore our pharmaceutical independence and take back control of our medicine cabinet. Andrew Rechenberg is an economist at the Coalition for a Prosperous America.
Newsweek
19 hours ago
- Newsweek
Gen Zer Films Himself Every Day—Then Uncovers a Shocking Truth
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A teenager has shared how he noticed the first symptom that led to his cancer diagnosis—by watching his own videos back. Felipe, 19, from Georgia, had recently moved to college in Oregon when he decided to take part in a viral health craze on TikTok. The Coconut Cult trend involves people documenting their daily intake of probiotic yogurt on TikTok and Instagram. But what he noticed watching back his videos wasn't digestive benefits—it was a lump forming in his neck. "I took the daily videos after seeing the craze with Coconut Cult and wanted to see any results from its daily intake," Felipe told Newsweek. "I noticed something was wrong after the left side of my neck appeared swollen; I saw it was curvy on the video, and then that's when I felt the bump." Pictures from the TikTok video that prompted Felipe to visit the emergency room. Pictures from the TikTok video that prompted Felipe to visit the emergency room. @felipedkl2/TikTok Concerned, Felipe sought medical attention, initially receiving a suspected diagnosis of bacterial infections like strep throat or mononucleosis. But doctors recommended a biopsy to be sure. "The ER had initially told me they suspected bacterial infections like strep throat or mononucleosis," Felipe said. "They immediately recommended a biopsy to see what's causing them to be inflamed." When that result came back, it wasn't what anyone was expecting—Felipe was diagnosed with Hodgkin's lymphoma, a type of cancer. What Is Hodgkin's Lymphoma? "Lymphoma is a cancer of the lymph glands, and if the lymph glands contain specific characteristic cells, they fall under the category of Hodgkin's lymphoma," Dr. Siddhartha Ganguly, section chief of hematology at Houston Methodist and an academic professor for Weill Cornell Medical College, told Newsweek. "It is relatively rare. There are only about 8,000 to 8,500 new cases across the country a year." Thankfully, when caught quickly, it is very treatable. "If we catch Hodgkin's lymphoma in the early stage of the disease, then the cure rate reaches as high as 95 percent to 98 percent in young Hodgkin's patients," Ganguly said. Felipe, who didn't share his surname, posted the video that prompted him to get checked out on TikTok where it now has over 722,000 views. Ganguly said the symptoms of Hodgkin's lymphoma you should look out for: "If somebody has enlargement of a gland, whether they have symptoms of unintentional weight loss, night sweats or fever, and the gland is present for more than seven to 10 days, see your primary care physician," he said. "They may prescribe an antibiotic to make sure it's not an infection. If it is still there after that antibiotic, make an appointment to see a hematologist who deals with lymphoma. The only way to make a diagnosis is through a biopsy." For Felipe, the next steps include a PET scan and chemotherapy sessions with the lymphoma medical team. He has continued to share parts of his journey on TikTok and remains positive, and is thankful for the support from viewers. "I feel better now that I have an answer. I'm taking things day by day," he said.
